Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Andrulionytė: Single Nucleotide Polymorphisms of the Peroxisome Proliferator–Activated.... (0.09 sec) 

PPAR agonists: multimodal drugs for the treatment of type-2 diabetes


B Gross, B Staels - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
Patients with type-2 diabetes mellitus (T2DM) are considered to be at
particularly high risk for cardiovascular disease. Over the last decade, the
members of the peroxisome proliferator-activated receptor (PPAR) subfamily ...
Cited by 19 - Related articles - All 15 versions

Single gene contributions: genetic variants of peroxisome proliferator-activated receptor ( …


EL Yong, J Li, MH Liu - Current Opinion in Lipidology, 2008 - journals.lww.com
Introduction The peroxisome proliferator-activated receptor (PPAR) isoforms (a,
g, and b/d) are key regulators of lipid/carbo- hydrate metabolism, adipogenesis,
and insulin sensi- tivity. Drugs targeting PPARa and PPARg are used to ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Interindividual variability in oral antidiabetic drug disposition and response: the role of …


MA Pacanowski, CW Hopley, CL Aquilante - Expert Opin. Drug Metab. Toxicol., 2008 - informahealthcare.com
Background: Numerous effective oral pharmacologic therapies are available to
treat type 2 diabetes. However, a substantial number of patients do not achieve
the expected glucose-lowering response, or may be predisposed to adverse ...
Cited by 2 - Related articles - BL Direct - All 6 versions

Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene


A Muise, D Rotin - Expert Review of Molecular Diagnostics, 2008 - ingentaconnect.com
Inflammatory bowel disease is a complex multifactorial disease with a strong
genetic component. Recent studies have identified innate immunity (NOD2),
autophagy (ATG16L1) and Th17 pathway (IL23R) genes in the pathogenesis of ...
Cited by 2 - Related articles - All 4 versions

[PDF] PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease


S Cresci - atherosclerosis - downloads.hindawi.com
The peroxisome proliferator-activated receptors (PPARs) consist of three related
transcription factors that serve to regulate a number of cellular processes that
are central to cardiovascular health and disease. Numerous pharmacologic ...
Cited by 1 - Related articles - View as HTML - All 15 versions

Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast …

- oxfordjournals.org
AK Golembesky, MD Gammon, KE North, JT … - Carcinogenesis, 2008 - Oxford Univ Press
Peroxisome proliferator-activated receptor-alpha (PPARA) has been shown to
increase fatty acid oxidation and decrease cytokine levels and has been
implicated in insulin production. Genetic variants of PPARA have been ...
Related articles - All 5 versions

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease


C Sharon - PPAR Research, 2008 - hindawi.com
The peroxisome proliferator-activated receptors (PPARs) consist of three related
transcription factors that serve to regulate a number of cellular processes that
are central to cardiovascular health and disease. Numerous pharmacologic ...
Related articles - Cached - All 2 versions

Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary …


C Fiévet, B Staels - Current Atherosclerosis Reports, 2009 - Springer
The greatest clinical challenge in type 2 diabetes mel- litus is the prevention
of its long-term complications, many of which are of a cardiovascular nature.
Despite the progress in cardiovascular risk management of diabetes patients ...
Related articles - All 2 versions

PPARα 基因多态性与 2 型糖尿病关系研究


陈雪香, 刘合焜 - 医学综述, 2008 - cqvip.com
首页; 期刊导航; 知识社区; 学者空间; 学术机构; 专题导读;
充值中心; 论文翻译. 登录 注册 帮助. 维普资讯 ...
Related articles - All 4 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google